A Multicenter, Randomized, Double-Blind, Phase 2 Study to Evaluate the Effect of Febuxostat Versus Placebo in Joint Damage in Hyperuricemic Subjects With Early Gout.
Phase of Trial: Phase II
Latest Information Update: 16 Nov 2016
At a glance
- Drugs Febuxostat (Primary)
- Indications Gout; Hyperuricaemia
- Focus Therapeutic Use
- Sponsors Takeda
- 16 Nov 2016 Results assessing frequency of acute flares presented at the 80th American College of Rheumatology and the 51st Annual Meeting of the Association of Rheumatology and Health Professionals
- 13 Nov 2016 Results published in the Takeda Media Release.
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.